 Nestlé SA, the maker of Gerber baby food and Nescafé instant coffee, is deepening its research into the link between diet and disease with an unusual biotechnology partnership that it hopes will help it develop more profitable products. . Under the deal, Nestlé will obtain brain and liver cells from Cellular Dynamics International Inc. and study how nutrients found in foods affect these human cells, according to Emmanuel Baetge, director of the Nestlé Institute of Health Sciences, a research arm of the Swiss company. Nestlé...
  